Insider Trading activities of Myokardia Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Myokardia Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Myokardia Inc since year 2005. Table 2 shows the detailed insider transactions of Myokardia Inc since 2005. The reporting company's ticker symbol is MYOK. The reporting company's CIK number is 1552451.
The total value of stock buying since 2005 is $28,337,855.
The total value of stock sales since 2005 is $74,905,960.
The total value of stock option exercises since 2005 is $75,825.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Myokardia Inc (MYOK).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-11 0 $0 4,300 $172,920 4,300 $6,480
2017-10 0 $0 79,613 $3,209,305 4,300 $6,480
2017-09 0 $0 1,629,600 $69,573,607 4,300 $6,480
2017-08 351,408 $12,474,984 44,300 $1,358,966 4,300 $6,480
2017-07 0 $0 37,321 $559,977 31,850 $48,093
2017-03 0 $0 2,079 $31,185 1,200 $1,812
2016-10 450,000 $6,750,000 0 $0 0 $0
2016-04 2,279 $19,371 0 $0 0 $0
2015-11 909,350 $9,093,500 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Myokardia Inc insiders (MYOK)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-11-06 Gianakakos Anastasios (President and CEO) Sale 4,300 40.21 172,920
2017-11-06 Gianakakos Anastasios (President and CEO) Option Ex 4,300 1.51 6,480
2017-10-04 Gianakakos Anastasios (President and CEO) Sale 4,300 40.86 175,698
2017-10-04 Gianakakos Anastasios (President and CEO) Option Ex 4,300 1.51 6,480
2017-10-03 Starr Kevin P (Director) Sale 75,313 40.28 3,033,607
2017-09-26 Starr Kevin P (Director) Sale 400,000 43.00 17,200,000
2017-09-26 Tepper Robert I (10% Owner) Sale 400,000 43.00 17,200,000
2017-09-25 Starr Kevin P (Director) Sale 201,400 43.00 8,660,200
2017-09-25 Tepper Robert I (10% Owner) Sale 201,400 43.00 8,660,200
2017-09-11 Tepper Robert I (10% Owner) Sale 20,000 44.25 885,080
2017-09-08 Starr Kevin P (Director) Sale 201,250 41.69 8,390,917
2017-09-08 Tepper Robert I (10% Owner) Sale 201,250 41.69 8,390,917
2017-09-05 Gianakakos Anastasios (President and CEO) Sale 4,300 43.32 186,293
2017-09-05 Gianakakos Anastasios (President and CEO) Option Ex 4,300 1.51 6,480
2017-08-22 Lambing Joseph (See Remarks) Sale 5,000 45.00 225,000
2017-08-15 Lambing Joseph (See Remarks) Sale 5,000 40.00 200,000
2017-08-14 Yarno Wendy L (Director) Buy 1,408 35.50 49,984
2017-08-14 Sanofi (10% Owner) Buy 350,000 35.50 12,425,000
2017-08-08 Lambing Joseph (See Remarks) Sale 5,000 35.00 175,000
2017-08-07 Lambing Joseph (See Remarks) Sale 10,000 27.50 275,000
2017-08-07 Bauer Jake (See Remarks) Sale 15,000 27.50 412,500
2017-08-04 Gianakakos Anastasios (President and CEO) Sale 4,300 16.62 71,466
2017-08-04 Gianakakos Anastasios (President and CEO) Option Ex 4,300 1.51 6,480
2017-07-25 Bauer Jake (See Remarks) Sale 4,333 15.02 65,059
2017-07-25 Gianakakos Anastasios (President and CEO) Sale 32,988 15.00 494,918
2017-07-25 Gianakakos Anastasios (President and CEO) Option Ex 31,850 1.51 48,093
2017-03-20 Bauer Jake (See Remarks) Sale 667 15.00 10,005
2017-03-20 Gianakakos Anastasios (President and CEO) Sale 1,412 15.00 21,180
2017-03-20 Gianakakos Anastasios (President and CEO) Option Ex 1,200 1.51 1,812
2016-10-03 Sanofi (10% Owner) Buy 450,000 15.00 6,750,000
2016-04-29 Gianakakos Anastasios (President and CEO) Buy 2,279 8.50 19,371
2015-11-03 Fox Jonathan C (Chief Medical Officer) Buy 3,000 10.00 30,000
2015-11-03 Gianakakos Anastasios (President and CEO) Buy 1,350 10.00 13,500
2015-11-03 Perry Mark L (Director) Buy 5,000 10.00 50,000
2015-11-03 Sanofi (10% Owner) Buy 900,000 10.00 9,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of MYOK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Myokardia Inc (symbol MYOK, CIK number 1552451) see the Securities and Exchange Commission (SEC) website.